Metropolis Healthcare has notified the stock exchanges of a scheduled analyst and institutional investor meeting, pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 08, 2026, outlines the company's participation in an upcoming investor conference.

Investor Meeting Details

The meeting is scheduled to be held on May 27, 2026, as part of the 360 ONE Capital (B&K) Investor Conference. The following table summarises the key details of the interaction:

Disclosure and Compliance

Metropolis Healthcare has confirmed that all discussions during the meeting will be based on publicly available information. The company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The company has also noted that changes to the schedule may occur due to exigencies on the part of participants, the host, or the company itself.

The intimation has been filed by Kamlesh C Kulkarni, Head – Legal & Secretarial, and is available on the company's website at www.metropolisindia.com .

Metropolis Healthcare Limited has announced its Q4FY26 earnings conference call, scheduled for May 14, 2026 at 9:00 am (IST). The call has been organized by Ambit Capital and is being held pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The conference will focus on the company's financial results for the quarter ended March 31, 2026. The intimation was filed on May 07, 2026, and signed by Kamlesh C Kulkarni, Head – Legal & Secretarial.

Company Representatives

The earnings call will feature participation from senior leadership across key functional roles. The following representatives are scheduled to attend:

• Ms. Ameera Shah – Chairperson & Whole-time Director
• Mr. Surendran Chemmenkotil – Managing Director
• Mr. Sameer Patel – Chief Financial Officer
• Mr. Avadhut Joshi – Chief Business Development Officer

The teleconference will be moderated by Gaurav Tinani from Institutional Equities, Ambit Capital.

Conference Call Details

Investors and analysts can participate in the call through the following access details. Participants are requested to dial in a few minutes prior to the scheduled time, and may register via Diamond Pass to avoid wait time.

Regulatory Compliance

The intimation has been filed in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The disclosure was submitted to both BSE Limited and the National Stock Exchange of India Ltd. on May 07, 2026.